ArticleEuropean heart journal. Case reports2025
Dysplasia of the tricuspid valve leading to recurrent atrial flutter and fibrillation: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial flutter (AFL) is usually effectively treated by cavotricuspid isthmus (CTI) ablation. If AFL recurs despite ablation, there is risk of progression to atrial fibrillation (AF) and clinicians should consider underlying structural heart diseases. This consideration becomes especially critical when right-heart-chambers are dilated. Case summary: A 50-year-old man presented with palpitations due to AFL. Fifteen years earlier, after polytrauma, mild tricuspid regurgitation (TR) and pericardial effusion had been diagnosed on transthoracic echocardiography (TTE). At present, TTE showed dilated right-heart-chambers and moderate TR. Despite two CTI-ablations, he developed AF for which he underwent pulmonary vein isolation (PVI). A further ablation was performed because of right-sided AFL due to transcrista conduction. Atrial fibrillation recurred, accompanied by heart failure. Tricuspid regurgitation severity and right-heart-chamber dilatation worsened. Finally, 3D-transoesophageal echocardiography (3D-TEE), performed 20 years after the first TTE, revealed that TR was due to restriction of the septal leaflet. The patient underwent surgery. The tricuspid valve was repaired by ring annuloplasty and a cleft between the anterior and septal leaflets was closed. Three years post-operatively, he is asymptomatic with chronic AF but no recurrent AFL. Transthoracic echocardiography shows only mild TR, though the right-heart-chambers remain dilated, likely due to long-standing TR. Discussion: Tricuspid regurgitation and AFL/AF have a bidirectional relationship. Tricuspid regurgitation can both cause and result from AFL/AF. Structural heart diseases, including post-traumatic valve damage, should be considered in patients with recurrent AFL despite CTI-ablation and progression to AF. In cases with TR and right-heart-chamber enlargement, 3D-TEE is essential for accurate diagnosis and should be performed without delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.